Scarica l'app Stockscreener
4.74
0.73%
-0.04
Dopo l'orario di chiusura:
4.75
0.010
+0.21%
Precedente Chiudi:
$4.78
Aprire:
$4.79
Volume 24 ore:
166.44K
Relative Volume:
0.96
Capitalizzazione di mercato:
$322.27M
Reddito:
$64.49M
Utile/perdita netta:
$-71.40M
Rapporto P/E:
-4.3486
EPS:
-1.09
Flusso di cassa netto:
$-52.00M
1 W Prestazione:
+3.15%
1M Prestazione:
-7.86%
6M Prestazione:
+51.11%
1 anno Prestazione:
+24.87%
Intervallo 1D:
$4.6132
$4.80
Intervallo di 1 settimana:
$4.6132
$5.06
Portata 52W:
$2.58
$5.70
Sophia Genetics Sa Stock (SOPH) Company Profile
Nome
Sophia Genetics Sa
Settore
Industria
Telefono
-
Indirizzo
-
Compare SOPH vs VEEV, TEM, BTSG, HQY, DOCS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
4.75 | 324.31M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
171.88 | 29.10B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
50.78 | 9.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
37.79 | 7.22B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
73.21 | 6.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
24.73 | 4.80B | 550.17M | 201.35M | 232.07M | 1.00 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Craig Hallum | Buy |
| 2024-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | Iniziato | Guggenheim | Buy |
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-03 | Iniziato | BTIG Research | Buy |
| 2022-11-23 | Iniziato | Credit Suisse | Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-17 | Iniziato | Cowen | Outperform |
| 2021-08-17 | Iniziato | Credit Suisse | Outperform |
| 2021-08-17 | Iniziato | JP Morgan | Overweight |
| 2021-08-17 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sophia Genetics Sa Borsa (SOPH) Ultime notizie
Day Trade: Can SOPHiA GENETICS SA sustain its profitabilityJuly 2025 Action & Long-Term Investment Growth Plans - baoquankhu1.vn
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems - Finviz
SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer - Quantisnow
Aug Wrap: Can SOPHiA GENETICS SA sustain its profitability2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn
Painful week for individual investors invested in SOPHiA GENETICS SA (NASDAQ:SOPH) after 11% drop, institutions also suffered losses - simplywall.st
VIX Spike: Is SOPHiA GENETICS SA benefiting from interest rate changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 68.3% - MarketBeat
SOPHiA GENETICS Expands Perceptive Credit Facility With New $25 Million Term Loan Capacity and Additional Warrants - The Globe and Mail
Sophia Genetics amends credit agreement to add $25 million in loan commitments By Investing.com - Investing.com Nigeria
Sophia Genetics amends credit agreement to add $25 million in loan commitments - Investing.com Nigeria
1,409,160 Shares in SOPHiA GENETICS SA $SOPH Bought by Alta Wealth Advisors LLC - Defense World
Market Trends: Is SOPHiA GENETICS SA a potential multi baggerWeekly Investment Summary & Capital Protection Trading Alerts - baoquankhu1.vn
SOPHiA GENETICS (NASDAQ:SOPH) Trading Down 0.7%Here's What Happened - MarketBeat
SOPH: Guggenheim Raises Price Target While Maintaining Buy Ratin - GuruFocus
Growth Recap: Is SOPHiA GENETICS SA a momentum stockJuly 2025 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Pharma News: Is SOPHiA GENETICS SA benefiting from interest rate changesSwing Trade & Growth Focused Stock Pick Reports - baoquankhu1.vn
Market Catalysts: Is SOPHiA GENETICS SA exposed to political riskQuarterly Performance Summary & AI Powered Market Entry Strategies - baoquankhu1.vn
Setup Watch: How does BTC Digital Ltd perform in inflationary periodsPortfolio Growth Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Stop Loss: Can SOPHiA GENETICS SA continue delivering strong returnsWeekly Trade Recap & Verified Swing Trading Watchlist - baoquankhu1.vn
Big Money Moves: Is SOPHiA GENETICS SA exposed to political riskWeekly Trade Review & Proven Capital Preservation Tips - baoquankhu1.vn
Why analysts recommend SOPHiA GENETICS SA (90B) stockMarket Performance Summary & Free Fast Entry Momentum Trade Alerts - bollywoodhelpline.com
Sentiment Review: Why is SOPHiA GENETICS SA stock going downJuly 2025 Drop Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Levels: Is SOPHiA GENETICS SA stock a hidden gemJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Inside the platform analyzing 1.8M genomes to speed cancer insights - Stock Titan
Executive hires to help startups scale - Startupticker.ch
Aug Final Week: Is SOPHiA GENETICS SA a potential multi baggerQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
SOPHiA GENETICS Announces CEO Transition and Strong Preliminary 2025 Results - TipRanks
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan - marketscreener.com
SOPHiA GENETICS reports 20% revenue growth, plans CEO transition By Investing.com - Investing.com UK
SOPHiA GENETICS Reports Strong Q3 Growth and Raises Guidance - MSN
Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleJuly 2025 Action & Growth Oriented Trade Recommendations - Улправда
Will SOPHiA GENETICS SA stock maintain dividend yieldMarket Sentiment Review & Daily Risk Controlled Trade Plans - ulpravda.ru
Why SOPHiA GENETICS SA stock remains on buy listsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - Улправда
Published on: 2026-01-09 00:00:10 - ulpravda.ru
Will SOPHiA GENETICS SA (90B) stock outperform global peersJuly 2025 Market Mood & High Accuracy Trade Alerts - ulpravda.ru
Is SOPHiA GENETICS SA stock ready for breakoutQuarterly Market Summary & Free Safe Entry Trade Signal Reports - Улправда
Income Plays: Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleWeekly Investment Recap & High Return Stock Watch Alerts - Улправда
MD Anderson, SOPHiA GENETICS Join for AI Oncology Boost - Mirage News
Aug Sectors: Is SOPHiA GENETICS SA stock ready for breakoutWeekly Trade Analysis & Long Hold Capital Preservation Tips - Bộ Nội Vụ
How SOPHiA GENETICS SA stock benefits from global expansionStock Rotation Strategies & Access Free Risk Analysis Before You Invest - ulpravda.ru
Tech Rally: Will SOPHiA GENETICS SA 90B stock outperform global peers2025 Market Outlook & Free Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Sophia Genetics stock rises on MD Anderson Cancer Center partnership - Investing.com
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology - Finviz
SOPHiA GENETICS and MD Anderson partner on AI-driven cancer care - Investing.com UK
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and Clover Health Investments (NASDAQ:CLOV) - Defense World
Will SOPHiA GENETICS SA stock benefit from upcoming earnings reports2026 world cup usa national team semifinals star players low block defense group prediction expert opinion - ulpravda.ru
Can Nirlon Limited (500307) Maintain Its ValuationMarket Capitalization Trends & Our Picks = Your Future Gains - bollywoodhelpline.com
RSI Reset May Fuel Rebound in Sanstar LimitedMerger & Acquisition Updates & Outperform With Our Smart Trading Calculator - bollywoodhelpline.com
Sophia Genetics Sa Azioni (SOPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
16.22%
2.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):